首页> 外国专利> Composition for Thrombolysis and Pharmaceutical Composition for Treating Diseases related to Blood Vessel Occlusion or Narrowness Comprising the Same

Composition for Thrombolysis and Pharmaceutical Composition for Treating Diseases related to Blood Vessel Occlusion or Narrowness Comprising the Same

机译:用于溶栓的组合物和用于治疗与血管阻塞或狭窄相关的疾病的药物组合物

摘要

The present invention relates to: a composition for dissolving thrombi comprising a peptide comprising the Arg-Gly-Asp motif; a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same; and a thrombus dissolving method and a method for treating stenotic or occlusive vascular diseases, comprising the step of administering the same. The compositions and methods of the present invention have the advantage that they effectively break down already formed thrombi by adopting the principle of targeting integrin within the thrombus such as platelet surface GPIIb-IIIa, which is not the same as the existing principle of plasminogen activation. Also, the compositions and methods of the present invention have a nerve-protecting function as they effectively open as far as the microvasculature, without the occurrence of restenosis after penetration.
机译:本发明涉及:用于溶解血栓的组合物,其包含含有Arg-Gly-Asp基序的肽。用于治疗狭窄或闭塞性血管疾病的药物组合物,包括该药物组合物;血栓溶解方法和治疗狭窄或闭塞性血管疾病的方法,包括给药步骤。本发明的组合物和方法的优点在于,它们通过采用靶向血栓内的整联蛋白的原理,例如血小板表面GPIIb-IIIa,有效地分解已经形成的血栓,这与现有的纤溶酶原激活的原理不同。而且,本发明的组合物和方法具有神经保护功能,因为它们有效地打开至微脉管系统,而在渗透后没有发生再狭窄。

著录项

  • 公开/公告号KR101463181B1

    专利类型

  • 公开/公告日2014-11-27

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20110112953

  • 发明设计人 허지회;권일;김영대;홍성유;

    申请日2011-11-01

  • 分类号A61K38/06;A61P9/10;A61P9;

  • 国家 KR

  • 入库时间 2022-08-21 15:01:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号